Torres-Narvaez Erika Sofia, Mendivelso-González Daniel Felipe, Artunduaga-Alvarado Juan Andrés, Ortega-Recalde Oscar
Departamento de Morfología, Facultad de Medicina e Instituto de Genética, Universidad Nacional de Colombia, Bogotá, D.C, Colombia.
Department of Pathology, Instituto Nacional de Cancerología, Bogotá, D.C, Colombia.
Front Oncol. 2025 Jul 9;15:1584178. doi: 10.3389/fonc.2025.1584178. eCollection 2025.
Next-generation sequencing (NGS) technologies have revolutionized research and precision medicine in patients with cancer. Progress in this area has been accompanied by the development of efficient and robust bioinformatics methods along with computational resources able to handle the growing amount and complexity of sequencing data. Importantly, the implementation of such approaches has not been uniform around the globe and several regions, including Latin American countries, remain lagging behind in cancer genomics and precision oncology. Likewise, numerous studies have highlighted the complexity and particularities of such populations in terms of genetic background, healthcare systems and human and technological resources. In this review, we aim to describe current clinical applications of NGS-based tests, focusing on their bioinformatics analyses and implementation in Latin America. Furthermore, we describe several opportunities for development, perspectives, and challenges that face genomic data analysis in this geographical area. We expect this review to provide an up-to-date overview of cancer genomics and bioinformatics in Latin America, serving as a valuable resource for both local and international cancer researchers.
下一代测序(NGS)技术彻底改变了癌症患者的研究和精准医学。这一领域的进展伴随着高效且强大的生物信息学方法的发展以及能够处理不断增长的测序数据量和复杂性的计算资源。重要的是,此类方法在全球的实施并不统一,包括拉丁美洲国家在内的几个地区在癌症基因组学和精准肿瘤学方面仍滞后。同样,众多研究强调了这些人群在遗传背景、医疗保健系统以及人力和技术资源方面的复杂性和特殊性。在本综述中,我们旨在描述基于NGS的检测的当前临床应用,重点关注其在拉丁美洲的生物信息学分析和实施情况。此外,我们描述了该地理区域基因组数据分析面临的几个发展机遇、前景和挑战。我们期望本综述能提供拉丁美洲癌症基因组学和生物信息学的最新概述,为本地和国际癌症研究人员提供宝贵资源。